Related Experiment Videos
Is the mitochondrial complex I ND5 gene a hot-spot for MELAS causing mutations?
Danae Liolitsa1, Shamina Rahman, Sarah Benton
1Neuromuscular Unit, Institute of Neurology, University College London, United Kingdom.
Annals of Neurology
|January 2, 2003
Summary
Two novel mitochondrial DNA mutations in the ND5 gene were found in patients with MELAS (mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes) and related disorders. These findings emphasize the role of Complex I dysfunction in MELAS.
Area of Science:
- Genetics
- Molecular Biology
- Neuroscience
Background:
- Mitochondrial DNA (mtDNA) mutations are implicated in various neurological disorders.
- Complex I (NADH:ubiquinone oxidoreductase) is crucial for cellular respiration.
- Mutations in the ND5 gene, encoding a Complex I subunit, are associated with MELAS.
Observation:
- Two novel heteroplasmic point mutations in the ND5 gene were identified.
- A 12770A-->G transition was found in a patient with MELAS.
- A 13045A-->C transversion was identified in a patient with a MELAS/Leber's hereditary optic neuropathy/Leigh's overlap syndrome.
Findings:
- Biochemical analyses revealed normal or only mildly reduced Complex I activity in muscle homogenates.
- Histochemical examinations showed no significant abnormalities.
- The identified mutations are novel and heteroplasmic, indicating they are not inherited from the mother and are present in a portion of the mtDNA population.
Implications:
- These findings support the frequent association of ND5 gene mutations with the MELAS phenotype.
- The study highlights the potential role of Complex I dysfunction in the pathogenesis of MELAS, even with seemingly mild biochemical alterations.
- Further research into the functional consequences of these specific ND5 mutations is warranted to understand their contribution to disease severity and phenotype variability.